{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:37:57Z","timestamp":1792802277048,"version":"4.5.0"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["2016-A-005-SUP"],"award-info":[{"award-number":["2016-A-005-SUP"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG049152"],"award-info":[{"award-number":["AG049152"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tau Consortium"},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG048017"],"award-info":[{"award-number":["R01 AG048017"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23 AG048291"],"award-info":[{"award-number":["K23 AG048291"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Alzheimer's Coordinating Center","award":["Junior Investigator Award"],"award-info":[{"award-number":["Junior Investigator Award"]}],"id":[{"id":"https:\/\/ror.org\/03qm4p447","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100003193","name":"Foundation of the American Society of Neuroradiology","doi-asserted-by":"publisher","award":["Alzheimer's Imaging Grant"],"award-info":[{"award-number":["Alzheimer's Imaging Grant"]}],"id":[{"id":"10.13039\/100003193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["Hillblom Aging Network"],"award-info":[{"award-number":["Hillblom Aging Network"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG023501"],"award-info":[{"award-number":["AG023501"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG1972403"],"award-info":[{"award-number":["AG1972403"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC1 AG035610"],"award-info":[{"award-number":["RC1 AG035610"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG26938"],"award-info":[{"award-number":["R01 AG26938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The John Douglas French Alzheimer's Foundation"},{"name":"Tau Consortium"},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P30 NS062691"],"award-info":[{"award-number":["P30 NS062691"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002272","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T14:55:55Z","timestamp":1490712955000},"page":"e1002272","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case\u2013control study"],"prefix":"10.1371","volume":"14","author":[{"given":"Natasha Z. R.","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-7494","authenticated-orcid":true,"given":"Jessie S.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke W.","family":"Bonham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan G.","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5991-3053","authenticated-orcid":true,"given":"Zachary A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-6017","authenticated-orcid":true,"given":"Rahul S.","family":"Desikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Boehme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. K.","family":"Kauwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-1061","authenticated-orcid":true,"given":"Giovanni","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Hollenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-2634","authenticated-orcid":true,"given":"Jennifer S.","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"ref1","unstructured":"Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M, et al. World Alzheimer Report 2015. The global impact of dementia: An analysis of prevalence, incidence, cost and trends. 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.alz.co.uk\/research\/world-report-2015\" xlink:type=\"simple\">https:\/\/www.alz.co.uk\/research\/world-report-2015<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/erm.10.48","article-title":"Advances and perspectives from genetic research: development of biological markers in Alzheimer\u2019s disease","volume":"10","author":"T Zetzsche","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 Variants in Alzheimer\u2019s Disease","volume":"368","author":"R Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 Associated with the Risk of Alzheimer\u2019s Disease","volume":"368","author":"T Jonsson","year":"2013","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2889.e11","DOI":"10.1016\/j.neurobiolaging.2013.06.004","article-title":"Assessment Of Trem2 Rs75932628 Association With Alzheimer\u2019s Disease In A Population-Based Sample: The Cache County Study","volume":"34","author":"JD Gonzalez Murcia","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-016-0367-7","article-title":"Rare TREM2 variants associated with Alzheimer\u2019s disease display reduced cell surface expression","volume":"4","author":"DW Sirkis","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1711.e15","DOI":"10.1016\/j.neurobiolaging.2012.12.018","article-title":"TREM2 is associated with risk of Alzheimer disease in Spanish population","volume":"34","author":"BA Benitez","year":"2013","journal-title":"Neurobiol Aging"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/hmg\/dds161","article-title":"Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer\u2019s diseases","volume":"21","author":"G Coppola","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"JC Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"AC Naj","year":"2011","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"CM Karch","year":"2015","journal-title":"Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2010-1414","article-title":"Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation","volume":"21","author":"K Hensley","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/glia.22866","article-title":"Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease","volume":"64","author":"PD Wes","year":"2016","journal-title":"Glia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1074\/jbc.M306183200","article-title":"Identification of Cathepsin B as a Mediator of Neuronal Death Induced by A\u03b2-activated Microglial Cells Using a Functional Genomics Approach","volume":"279","author":"L Gan","year":"2004","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"S Hong","year":"2016","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt118","article-title":"Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer\u2019s disease","volume":"4","author":"P Eikelenboom","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","article-title":"Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study","volume":"52","author":"R Schmidt","year":"2002","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2005-8406","article-title":"Potential inflammatory biomarkers in Alzheimer\u2019s disease","volume":"8","author":"RE Mrak","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(93)91327-O","article-title":"Cytokine indices in Alzheimer\u2019s temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein","volume":"629","author":"JA Wood","year":"1993","journal-title":"Brain Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","article-title":"Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline","volume":"35","author":"Q Shi","year":"2015","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","article-title":"A Dramatic Increase of C1q Protein in the CNS during Normal Aging","volume":"33","author":"AH Stephan","year":"2013","journal-title":"J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/oxfordjournals.epirev.a018034","article-title":"HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review","volume":"22","author":"JS Dorman","year":"2000","journal-title":"Epidemiol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1212\/NXG.0000000000000012","article-title":"Late-onset Alzheimer disease risk variants mark brain regulatory loci","volume":"1","author":"M Allen","year":"2015","journal-title":"Neurol Genet"},{"key":"ref24","first-page":"1","article-title":"Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease","volume":"94158","author":"JS Yokoyama","year":"2016","journal-title":"JAMA Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"B Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref26","unstructured":"Boehme KL, Young B, Mukherjee S, Crane PK, Kauwe J, Young B. ADGC 1000 Genomes combined data workflow. 2014; 1\u201312. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/kauwelab.byu.edu\/Portals\/22\/adgc_combined_1000G_12032014.pdf\" xlink:type=\"simple\">http:\/\/kauwelab.byu.edu\/Portals\/22\/adgc_combined_1000G_12032014.pdf<\/ext-link>"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0339-y","article-title":"The relationship between complement factor C3, APOE \u03b54, amyloid and tau in Alzheimer\u2019s disease","volume":"4","author":"LW Bonham","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2013.4560","article-title":"The role of clusterin in amyloid-\u03b2-associated neurodegeneration","volume":"71","author":"RS Desikan","year":"2014","journal-title":"JAMA Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-8-39","article-title":"Heart fatty acid binding protein and A\u03b2-associated Alzheimer\u2019s neurodegeneration","volume":"8","author":"RS Desikan","year":"2013","journal-title":"Mol Neurodegener"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"JC Morris","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans","volume":"6","author":"AJ Saykin","year":"2010","journal-title":"Alzheimers Dement"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"LM Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"ref33","unstructured":"Rey A. L\u2019examen clinique en psychologie. Lexamen clinique en psychologie. 1958."},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"WG Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"ref35","first-page":"627","article-title":"Alzheimer\u2019s Disease Assessment Scale (ADAS)","volume":"24","author":"CL Mohs RC","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"CP Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/tpj.2015.4","article-title":"High-accuracy imputation for HLA class I and II genes based on high-resolution SNP data of population-specific references","volume":"15","author":"S-S Khor","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/tpj.2013.18","article-title":"HIBAG\u2014HLA genotype imputation with attribute bagging","volume":"14","author":"X Zheng","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humimm.2015.12.006","article-title":"Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline","volume":"77","author":"DJ Pappas","year":"2016","journal-title":"Hum Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.536","article-title":"Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions","volume":"42","author":"VM Van Deerlin","year":"2010","journal-title":"Nat Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-61779-842-9_14","article-title":"Analytical methods for disease association studies with immunogenetic data","volume":"882","author":"JA Hollenbach","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.humimm.2007.04.005","article-title":"High resolution HLA alleles and haplotypes in the US population","volume":"68","author":"M. Maiers","year":"2007","journal-title":"Human Immunology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0197-4580(00)00164-0","article-title":"Relationship between apoE genotype and CSF \u03b2-amyloid (1\u201342) and tau in patients with probable and definite Alzheimer\u2019s disease","volume":"21","author":"T Tapiola","year":"2000","journal-title":"Neurobiol Aging"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamaneurol.2016.0980","article-title":"Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis","volume":"73","author":"N Isobe","year":"2016","journal-title":"JAMA Neurol"},{"issue":"16","key":"ref45","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis","volume":"278","author":"LA Farrer","year":"1997","journal-title":"JAMA"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00702-006-0485-7","article-title":"Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer\u2019s disease","volume":"113","author":"H Kessler","year":"2006","journal-title":"J Neural Transm"},{"key":"ref47","first-page":"443","article-title":"Alzheimer disease: evidence for susceptibility loci on chromosomes 6 and 14","volume":"35","author":"LR Weitkamp","year":"1983","journal-title":"Am J Hum Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1212\/WNL.49.2.512","article-title":"Evidence for association of HLA-A2 allele with onset age of Alzheimer\u2019s disease","volume":"49","author":"H Payami","year":"1997","journal-title":"Neurology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.41.10.1544","article-title":"HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer\u2019s disease in men","volume":"41","author":"H Payami","year":"1991","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0404.1998.tb01735.x","article-title":"Association of the HLA-A2 allele with an earlier age of onset of Alzheimer\u2019s disease","volume":"98","author":"O Combarros","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.neurobiolaging.2008.02.001","article-title":"Association study of the HLA-A2 allele in Italian Alzheimer disease patients","volume":"30","author":"FR Guerini","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/rej.2006.9.99","article-title":"Association between the HLA-A2 allele and Alzheimer disease","volume":"9","author":"F List\u00ec","year":"2006","journal-title":"Rejuvenation Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000164275","article-title":"Association between HLA-A alleles and Alzheimer\u2019s disease in a southern Chinese community","volume":"26","author":"SL Ma","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(02)01057-1","article-title":"No association of the HLA-A2 allele with Alzheimer\u2019s disease","volume":"335","author":"L Araria-Goumidi","year":"2002","journal-title":"Neurosci Lett"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.58.6.973","article-title":"HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease","volume":"58","author":"S Zareparsi","year":"2002","journal-title":"Neurology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)01539-1","article-title":"Human leucocyte antigen-A2 increases risk of Alzheimer\u2019s disease but does not affect age of onset in a Scottish population","volume":"294","author":"JM Harris","year":"2000","journal-title":"Neurosci Lett"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s100480050080","article-title":"No association between the HLA-A2 allele and Alzheimer disease","volume":"2","author":"GW Small","year":"1999","journal-title":"Neurogenetics"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0197-4580(91)90026-G","article-title":"Variable association of HLA-A2 in men with early-onset Alzheimer disease","volume":"12","author":"GW Small","year":"1991","journal-title":"Neurobiol Aging"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1531-8249(199903)45:3<397::AID-ANA18>3.0.CO;2-4","article-title":"HLA A2 allele is associated with age at onset of Alzheimer\u2019s disease","volume":"45","author":"C Ballerini","year":"1999","journal-title":"Ann Neurol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/039463200902200414","article-title":"HLA-A*01 is associated with late onset of Alzheimer\u2019s disease in Italian patients","volume":"22","author":"FR Guerini","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0304-3940(99)00045-2","article-title":"Frequency of HLA-A and B alleles in early and late-onset Alzheimer\u2019s disease","volume":"262","author":"D Middleton","year":"1999","journal-title":"Neurosci Lett"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MAJ.0000000000000416","article-title":"Association of HLA-DR\/DQ polymorphism with Alzheimer\u2019s disease","volume":"349","author":"L Mansouri","year":"2015","journal-title":"Am J Med Sci"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.0150","article-title":"Association between genetic traits for immune-mediated diseases and Alzheimer disease","volume":"73","author":"JS Yokoyama","year":"2016","journal-title":"JAMA Neurol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/429393","article-title":"A High-Resolution Linkage-Disequilibrium Map of the Human Major Histocompatibility Complex and First Generation of Tag Single-Nucleotide Polymorphisms","volume":"76","author":"MM Miretti","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0197-4580(00)00180-9","article-title":"HLA class I, II &amp; III genes in confirmed late-onset Alzheimer\u2019s disease","volume":"22","author":"DJ Lehmann","year":"2001","journal-title":"Neurobiol Aging"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(99)00761-2","article-title":"Risk for Alzheimer\u2019s disease in older late-onset cases is associated with HLA-DRB1*03","volume":"275","author":"D Neill","year":"1999","journal-title":"Neurosci Lett"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/aje\/kwk118","article-title":"HLA-DR15 haplotype and multiple sclerosis: a HuGE review","volume":"165","author":"H Schmidt","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"S Sawcer","year":"2011","journal-title":"Nature"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e1003926","DOI":"10.1371\/journal.pgen.1003926","article-title":"Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects","volume":"9","author":"NA Patsopoulos","year":"2013","journal-title":"PLoS Genet"},{"key":"ref70","article-title":"Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients","author":"AP Lysandropoulos","year":"2016","journal-title":"Acta Neurol Belg"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"WT Wissemann","year":"2013","journal-title":"Am J Hum Genet"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies","volume":"377","author":"MA Nalls","year":"2011","journal-title":"Lancet"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/242048","article-title":"The Relationship of HLA Class I and II Alleles and Haplotypes with Autism: A Case Control Study","volume":"2014","author":"M Al-Hakbany","year":"2014","journal-title":"Autism Res Treat"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"DQB1 Locus Alone Explains Most of the Risk and Protection in Narcolepsy with Cataplexy in Europe","volume":"37","author":"M Tafti","year":"2014","journal-title":"Sleep"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.genom.4.070802.110432","article-title":"The genetics of narcolepsy","volume":"4","author":"D Chabas","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref76","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"E Mignot","year":"1997","journal-title":"Sleep"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/sleep\/33.1.29","article-title":"Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?","volume":"33","author":"NF Watson","year":"2010","journal-title":"Sleep"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jalz.2015.03.003","article-title":"APOE effect on Alzheimer\u2019s disease biomarkers in older adults with significant memory concern","volume":"11","author":"SL Risacher","year":"2015","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2164-15-81","article-title":"Predicting HLA genotypes using unphased and flanking single-nucleotide polymorphisms in Han Chinese population","volume":"15","author":"A-R Hsieh","year":"2014","journal-title":"BMC Genomics"},{"key":"ref80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002877","article-title":"Multi-Population Classical HLA Type Imputation","volume":"9","author":"A Dilthey","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaneurol.2014.3049","article-title":"Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease","volume":"72","author":"L Yu","year":"2015","journal-title":"JAMA Neurol"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T15:56:40Z","timestamp":1588953400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002272"}},"subtitle":[],"editor":[{"given":"Carol","family":"Brayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":81,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002272","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}